Bohui Innovation: First Quarter Report for 2026

SZSIApr 28 00:00 · Announcements

Bohui Innovation (300318.SZ) reported a net loss of 91.9232 million yuan in 2025.

Gelonghui, April 25th ┃ Bohui Innovation (300318.SZ) released its 2025 annual report, showing that the company achieved a total operating revenue of 825 million yuan for the full year, representing a year-on-year decline of 3.18%; net profit attributable to shareholders was -91.9232 million yuan; non-recurring net profit attributable to shareholders was -66.7938 million yuan.

Gelonghui FinanceApr 25 12:27

Bohui Innovation: Summary of the 2025 Annual Report

SZSIApr 25 00:00 · Announcements

Bohui Innovation: 2025 Annual Report

SZSIApr 25 00:00 · Announcements

Bohui Innovation (300318.SZ): Signs 'Equity Entrustment Agreement' with Controlling Shareholder

Gelonghui, February 4th: Bohui Innovation (300318.SZ) announced that the company's controlling shareholder and Mr. Du Jiangtao, a shareholder of Bohui Biopharmaceuticals (Hebei) Co., Ltd. (hereinafter referred to as "Hebei Bohui"), signed an Equity Transfer Agreement with Beijing Tongying Investment Group Co., Ltd. (hereinafter referred to as "Tongying Group") to acquire 14.7001% of Hebei Bohui’s shares held by Tongying Group. To safeguard the independence of the company and avoid actual or potential competition between the controlling shareholder and the company, Mr. Du Jiangtao, the company's controlling shareholder, plans to sign an Equity Entrustment Agreement with the company, intending to entrust the acquired shares of Hebei Bohui.

Gelonghui FinanceFeb 4 17:42

Nipah Virus Draws Attention as Diagnostic Kits Race Ahead, but Barriers Remain for Antiviral Drug Development

①The recent cluster outbreak of the Nipah virus in India has been relatively small-scale, with no reported cases of regional spillover so far; ②The related market movements in this instance are essentially typical event-driven speculative trading, with only a few areas having a short-term basis for earnings realization.

cls.cnJan 30 20:46